Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

The trials will test the ability of the firm's fluorine-18 labeled PET tracer to detect FAP-expressing tumor cells in ...

A mum who put night sweats, aching joints and unusual bleeding down to the menopause had just been given the all clear after ...

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...

Researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing ...

Little Harry Buckland finally made it home just in time for Christmas with his family after a long year of chemotherapy, ...

What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Dr James McGee, the newly appointed president of the OSF Healthcare Cancer Institute, is working to bring world-class cancer ...